Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma

被引：0
|
作者：
Javier Sanchez Alvarez
Mahmoud Jaber
Marie-Hélène Blanchet Zumofen
机构：
[1] F. Hoffmann-La Roche Ltd,
来源：
Oncology and Therapy | 2023年 / 11卷
关键词：
Bayesian analysis; Follicular lymphoma; Mosunetuzumab; Real-world data; Survival; Third-line therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 511
页数：16
相关论文
共 50 条
  • [21] Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up
    Kaufmann, Maxi
    Haase, Rocco
    Proschmann, Undine
    Ziemssen, Tjalf
    Akguen, Kafja
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [22] Investigating long-term complications of gestational diabetes using real-world data
    Goldet, G.
    Tam, F.
    Frankel, A.
    Ul-Haq, Z.
    Dattani, R.
    Kamalati, T.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S193 - S193
  • [23] Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy
    Mcgough, Sarah F.
    Shamas, Natasha
    Wang, Jue
    Jaber, Mahmoud
    Swarup, Binay
    Zumofen, Marie-Helene Blanchet
    Lautie, Bertrand
    Parreira, Joana
    Wei, Michael C.
    Shewade, Ashwini
    LEUKEMIA & LYMPHOMA, 2023, 64 (14) : 2269 - 2278
  • [24] ASSESSING THE IMPROVED PRECISION OF EXTRAPOLATED SURVIVAL ESTIMATES WHEN INCORPORATING REAL-WORLD DATA IN BAYESIAN MSPLINE MODELS
    Timmins, I
    Torabi, F.
    Williams, J.
    Hettle, R.
    Jackson, C. H.
    Lambert, P. C.
    Sweeting, M. J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [25] Long-Term Effectiveness and Drug Survival of Apremilast in Treating Psoriasis: A Real-World Experience
    Distel, Julian
    Cazzaniga, Simone
    Seyed Jafari, S. Morteza
    Emelianov, Vladimir
    Schlapbach, Christoph
    Yawalkar, Nikhil
    Heidemeyer, Kristine
    DERMATOLOGY, 2022, 238 (02) : 267 - 275
  • [26] Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry
    Jan Hugo
    Martina Kojanova
    Barbora Turkova
    Spyridon Gkalpakiotis
    Dermatology and Therapy, 2023, 13 : 787 - 801
  • [27] Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry
    Hugo, Jan
    Kojanova, Martina
    Turkova, Barbora
    Gkalpakiotis, Spyridon
    BIOREP Study Grp
    DERMATOLOGY AND THERAPY, 2023, 13 (03) : 787 - 801
  • [28] Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data
    Noteboom, S.
    Strijbis, E. M. M.
    Coerver, E. M. E.
    Colato, E.
    van Kempen, Z. L. E.
    Jasperse, B.
    Vrenken, H.
    Killestein, J.
    Schoonheim, M. M.
    Steenwijk, M. D.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 87
  • [29] Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study
    Serban, Teodora
    Allara, Roberto
    Azzolini, Valeria
    Bellintani, Claudio
    Belloli, Laura
    Belai Beyene, Nebiat
    Bucci, Romano
    Caporali, Roberto
    Cappelli, Antonella
    Corbelli, Vincenzo
    De Gennaro, Fabio
    Fusaro, Enrico
    Giusti, Andrea
    Govoni, Marcello
    Magnani, Luca
    Manzo, Ciro
    Romano, Ciro
    Rossini, Maurizio
    Santilli, Daniele
    Saviola, Gianantonio
    Sinigaglia, Luigi
    Bianchi, Gerolamo
    MINERVA MEDICA, 2021, 112 (02) : 246 - 254
  • [30] Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Christoph
    Schmidt, Stephan
    Ettle, Benjamin
    Schulze-Topphoff, Ulf
    FRONTIERS IN NEUROLOGY, 2021, 12
12345